The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.
about
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementiaRelapse risk after discontinuation of risperidone in Alzheimer's disease.Neuroleptic equivalent dose differences and behavioral and psychological symptoms of dementia.
P2860
The antipsychotic discontinuation in Alzheimer disease trial: clinical rationale and study design.
description
2012 nî lūn-bûn
@nan
2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
The antipsychotic discontinuat ...... al rationale and study design.
@ast
The antipsychotic discontinuat ...... al rationale and study design.
@en
type
label
The antipsychotic discontinuat ...... al rationale and study design.
@ast
The antipsychotic discontinuat ...... al rationale and study design.
@en
prefLabel
The antipsychotic discontinuat ...... al rationale and study design.
@ast
The antipsychotic discontinuat ...... al rationale and study design.
@en
P2093
P2860
P1476
The antipsychotic discontinuat ...... al rationale and study design.
@en
P2093
Bruce Levin
Corbett Schimming
D P Devanand
Danilo de la Pena
David Sultzer
Gregory H Pelton
Howard Andrews
Jacobo Mintzer
Sanjay Gupta
Susan Schultz
P2860
P304
P356
10.1097/JGP.0B013E3182110563
P577
2012-04-01T00:00:00Z